21Nov
21Nov
Akston Begins Trials For Room Temperature Covid Shot As Next-Generation Vaccine Race Heats Up
Massachusetts-based Akston Biosciences launched mid-to-late stage clinical trials for its Covid-19 vaccine Saturday. Read more >>
21Nov
Kalion completes first full-scale glucaric acid fermentation
The industrial biotech start-up Kalion says it has collected several tons of glucaric acid from its first full-scale fermentation, conducted by Evonik Industries. Read more >>
19Nov
Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods
Silo Pharma, Inc. a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that their joint venture partner Zylo Therapeutics received its first ketamine shipment and initiated loading ketamine into their Z-Pod® transdermal technology. Read more >>
18Nov
Zebware’s ZebClient® Partners with Wasabi Technologies to Deliver Ultra-Performant Data Lakes at a Disruptively Affordable Price
The Swedish software company Zebware and Wasabi Technologies, the hot cloud storage company, join forces to enable low-cost, scalable, and ultra-performant cloud-based data lakes. Read more >>
17Nov
Client Success Stories – Archer Roose
Going into 2020, Archer Roose was growing at around 100% year-over-year. The brand had just taken flight aboard JetBlue, being served nationally on all flights and the Company was getting ready to announce a major partnership with a big hospitality partner. And then, of course, COVID hit. Within moments, 80% of their revenue dried up… overnight. Marian quickly found herself rebuilding the entire business model and pivoting the Company from the ground up. All of this, on top of giving...
17Nov
Pyramid Biosciences Expands Precision Oncology Pipeline
Pyramid Biosciences, Inc., a clinical-stage biotechnology company developing a portfolio of precision therapies targeting a wide range of diseases, today announced the global licensing of the novel monopolar spindle1 (MPS1) called VRN-08 and a second undisclosed asset from Voronoi Inc., a South Korea-based biotechnology company the develops novel kinase inhibitors and target protein degraders. The milestone-based deal is worth up $846 million dollars (USD). Read more >>
17Nov
S’More Among First Dating Apps In The World To Use AWS Rekognition to Verify 100% of Users and Create a Safer Dating Environment
S’More, the anti-superficial dating app founded by former Magic Labs executive Adam Cohen-Aslatei, announced it is using advanced Amazon Web Services (AWS) cloud services to build one of the safest and most secure dating apps on the market. Read more >>
16Nov
New Hampshire Society for Technology in Education (NHSTE) Partners with Scrible to Help Schools Affordably Access Its Research and Writing Platform
Scrible, a modern research and writing platform for students, teachers and librarians, announced today a new partnership with the New Hampshire Society for Technology in Education (NHSTE) to provide the state's K12 schools access to its software at a reduced price. Read more >>
12Nov